Enzo's Q2 Revenues Improve 5 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Monday a 5 percent increase year over year in fiscal second-quarter revenues.

For the three months ended Jan. 31, total revenues rose to $25.0 million from $23.7 million driven by growth in the company's Clinical Labs segment and an increase in royalty and licensing revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.